Trial Profile
Effect of very long term treatment with imatinib in patients with chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Therapeutic Use
- 30 Jul 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.